
Oncology NEWS International
- Oncology NEWS International Vol 11 No 1
- Volume 11
- Issue 1
Ethnicity and Pain Reviewed
ALBUQUERQUE-"Ethnicity is a relatively understudied concept in pain medicine," David B. Morris, PhD, writes in his review of ethnicity and pain (Pain Clinical Updates vol. IX, no. 4, November 2001). Existing research, he said, has provided "few firm generalizations" about the relationship between ethnicity and pain. This is due, in part, to the fact that both pain and ethnicity are "multidimensional, malleable, and shaped by culture."
ALBUQUERQUE"Ethnicity is a relatively understudied concept in pain medicine," David B. Morris, PhD, writes in his review of ethnicity and pain (Pain Clinical Updates vol. IX, no. 4, November 2001). Existing research, he said, has provided "few firm generalizations" about the relationship between ethnicity and pain. This is due, in part, to the fact that both pain and ethnicity are "multidimensional, malleable, and shaped by culture."
Some studies suggest that minorities are less likely to receive adequate treatment for pain. Dr. Morris pointed to a US study that found no differences in the amount of opioid self-administered for acute pain among different ethnic groups, but significant differences in the amount of opioid prescribed.
Even when the prescription is adequate, he noted, "ethnic groups face inequalities that translate into poorly controlled pain." For example, pharmacies in poor, nonwhite neighborhoods may not stock adequate supplies of opioids.
Finally, Dr. Morris emphasized that although there may be measurable differences in how different ethnic groups experience pain, there are also "deep similarities." Studies of specific conditions, from cancer to childbirth, have found "major similarities among various ethnocultural groups in pain perception and response," he said.
Articles in this issue
over 23 years ago
ODAC Sends Mixed Message on New Gliadel Wafer Indicationalmost 24 years ago
ONCC Certification Test Results Are Announcedalmost 24 years ago
Rituximab Ups Survival in Aggressive and Indolent NHLalmost 24 years ago
Topotecan Used in Aggressive Front-Line Therapy for SCLCalmost 24 years ago
Depsipeptide Shows Activity in T-Cell Lymphomaalmost 24 years ago
FDG-PET Useful in Newly Diagnosed and Recurrent NSCLCalmost 24 years ago
Adjuvant Anastrozole Superior to Tamoxifen in Huge ATAC Breast Cancer Trialalmost 24 years ago
ODAC Backs Adding HER-2 DNA Test to Herceptin Package Insertalmost 24 years ago
FDA and VA Plan Joint AIDS Studyalmost 24 years ago
Breast Conservation Increases With On-Site Radiation UnitNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































